MusclePharm Makes Strategic Investment in Fuse Science, Inc.
November 08 2013 - 4:01PM
Marketwired
MusclePharm Makes Strategic Investment in Fuse Science, Inc.
Fuse Science(R) Is an Innovative Consumer Products and Delivery
Technology Company
DENVER, CO--(Marketwired - Nov 8, 2013) - MusclePharm
Corporation (OTCQB: MSLP) ("MusclePharm"), a leading international,
award-winning sports nutrition company, announced today it has made
a strategic investment in Fuse Science, Inc. (OTCQB: DROP)
("Fuse").
MusclePharm's investment was part of a larger investment from
several other prominent investors, many of whom also participated
in MusclePharm's $12 million registered direct public offering in
early 2013. MusclePharm's financial interest is part of on-going
discussions that may lead to a more meaningful strategic
relationship between MusclePharm and Fuse Science®.
Fuse Science, Inc. is an innovative consumer products and
delivery technology company based in Miami Lakes,
Florida. Fuse Science® holds the rights to new, patent-pending
technologies poised to redefine how consumers receive energy,
medicines, vitamins and minerals. Fuse Science® maintains the
rights to sublingual and transdermal delivery systems for bioactive
agents that can now, for the first time, effectively encapsulate
and charge many varying molecules in order to produce complete
product formulations which can bypass the gastrointestinal tract
and enter the blood stream directly -- all in a concentrated "DROP"
form that is simply applied under the tongue. The Fuse
Science® technology is designed to accelerate conveyance of
medicines or nutrients relative to traditional pills and liquids
and can enhance how consumers receive these products. Information
about Fuse Science® is available online at www.fusescience.com and
www.poweredbyfuse.com.
"The investment in Fuse emanates from our interest in its
delivery technology and products," stated Brad Pyatt, Founder and
CEO of MusclePharm. "It is aligned with our strategy of leveraging
our marketing and distribution channels while bringing both
innovation and sophistication to the sport nutrition market. We
look forward to continuing ongoing discussions with the Fuse
management team and exploring various possibilities for a mutually
advantageous strategic relationship."
ABOUT MUSCLEPHARM CORPORATION
MusclePharm® is a leading international, award-winning sports
nutrition company offering vitamins and nutritional supplements
which are available in more than 110 countries and available in
15,000+ U.S. retail outlets, including Costco, Dick's Sporting
Goods, 24 Hour Fitness, Bally's, GNC, Vitamin Shoppe and Vitamin
World. The company's brands are MusclePharm®, Arnold
Schwarzenegger Series™, and FitMiss™. The comprehensive lines of
clinically-proven, safe and effective nutritional supplements are
developed through a six-stage research process that utilizes the
expertise of leading nutritional scientists, doctors and
universities. For more information, visit www.musclepharmcorp.com.
Follow the company at http://www.facebook.com/MusclePharm and
www.Twitter.com/MusclePharm.
FORWARD-LOOKING STATEMENTS
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities and Exchange Act of 1934, as
amended. Statements that are not a description of historical facts
constitute forward-looking statements and may often, but not
always, be identified by the use of such words as "expects",
"anticipates", "intends", "estimates", "plans", "potential",
"possible", "probable", "believes", "seeks", "may", "will",
"should", "could" or the negative of such terms or other similar
expressions. Actual results may differ materially from those set
forth in this release due to the risks and uncertainties inherent
in the Company's business. More detailed information about the
Company and the risk factors that may affect the realization of
forward-looking statements is set forth in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2012,
the Company's Quarter Reports on Form 10-Q and other filings
submitted by the Company to the SEC, copies of which may be
obtained from the SEC's website at www.sec.gov. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and the Company undertakes no obligation to
revise or update this release to reflect events or circumstances
after the date hereof.
MusclePharm Investor Contact: The Del Mar Consulting Group, Inc.
Robert B. Prag President Telephone: 858-794-9500 Email: Email
Contact or Alex Partners, LLC Scott Wilfong President Telephone:
425-242-0891 Email: Email Contact
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Jul 2024 to Aug 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Aug 2023 to Aug 2024